Cargando…
Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions
BACKGROUND: The new nine-valent vaccine against human papillomavirus (HPV) includes the four HPV genotypes (6, 11, 16, and 18) that are targeted by the older quadrivalent HPV vaccine, plus five additional oncogenic types (31, 33, 45, 52, and 58) remain significantly associated with high grade lesion...
Autores principales: | Paz-Zulueta, María, Álvarez-Paredes, Ledicia, Rodríguez Díaz, Juan Carlos, Parás-Bravo, Paula, Andrada Becerra, Ma. Encarnación, Rodríguez Ingelmo, José María, Ruiz García, María Montserrat, Portilla, Joaquín, Santibañez, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791190/ https://www.ncbi.nlm.nih.gov/pubmed/29382323 http://dx.doi.org/10.1186/s12885-018-4033-2 |
Ejemplares similares
-
Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States
por: Gee, Julianne, et al.
Publicado: (2016) -
Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2017) -
High risk HPV genotypes in Belarus
por: Eremin, VF, et al.
Publicado: (2014) -
Comparison of the Digene HPV Genotyping LQ Test and the PANArray HPV Genotyping Chip for Detection of High-Risk or Probable High-Risk Human Papillomavirus Genotypes
por: Park, Kyung Sun, et al.
Publicado: (2014) -
HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test
por: Halfon, Philippe, et al.
Publicado: (2013)